跳至主要内容
临床试验/ITMCTR2000003243
ITMCTR2000003243尚未招募1 期

Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19)

Beijing University of Chinese Medicine Third Affiliated Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • (1) Convalescent patients with novel coronavious pneumonia,and the patient is aged 18-75 years old;
  • (2) The TCM syndrome type conforms to deficiency of 'qi' and 'yin' and not exhausted of 'Yu Xie';
  • (3) Voluntary test, or the immediate family or the client's approved client agrees to the test, and voluntarily signs the informed consent;
  • (4) Provide detailed contact information, no short-term willingness to move and be willing to cooperate with followers.

排除标准

  • (1) Patients with fasting water due to gastrointestinal bleeding, intestinal obstruction, etc;
  • (2) Patients with pre-existing severe brain, heart, liver, kidney and hematopoietic system diseases;
  • (3) Patients who are known to be allergic to the ingredients of the intervention drug;
  • (4) Patients who are unable to cooperate with follow-up.

研究者

发起方
Beijing University of Chinese Medicine Third Affiliated Hospital

相似试验